Vaccine

Virus-like particles containing a protein from human metapneumovirus are a promising vaccine candidate for this respiratory virus. Read More

(Vanderbilt University) Potentially “game-changing” research at Vanderbilt University on infectious diseases, population health and health policy will be showcased during two interactive presentations May 15 and May 22. A segment of the Flexner Discovery Lecture Series, the new “Vanderbilt Cutting-edge Discovery” discussions are highlights of recent presentations… Read More

World Health Day 2014 Shines Spotlight on Mosquito-borne Viral Diseases Female Ades aegypti mosquito. Photo courtesy of the CDC Image Library. Chikungunya virus, a vector-borne disease that is quickly spread by mosquitoes and causes victims to suffer severe fever and pain, has reached the… Read More

Understanding how HIV infection affects immune system B cells may guide strategies for vaccine development. Read More

Vanderbilt University and Medical Center faculty, staff, students and volunteers will once again have the opportunity to be part of a mass flu vaccination event that two years ago more than doubled the current world record for the total number of vaccinations given in an eight-hour period. Read More

Vanderbilt University investigators have developed a new strategy for identifying the “bits” of a pathogen that spark a protective immune response. Read More

Collaborating researchers at the University of North Carolina and Vanderbilt University have found that accelerating the rate of mutations in the coronavirus responsible for deadly severe acute respiratory syndrome (SARS) cripples the virus’s ability to cause disease in animals. Read More

The structural architecture of the reovirus attachment protein is required for efficient reovirus infection of host cells. Read More

(Susan Urmy/Vanderbilt) Additional volunteers are needed Oct. 17 and 18 to assist with this year’s Flulapalooza, where Vanderbilt University and Medical Center faculty, staff, students and volunteers can quickly receive their flu vaccination during a mass flu vaccination plan. While exempt employees are encouraged to participate as volunteers, non-exempt… Read More

Vanderbilt University and Medical Center faculty, staff, students and volunteers will once again have the opportunity to be part of a mass flu vaccination plan that last year more than doubled the then-world record for the total number of vaccinations given in an eight-hour period. Read More

Understanding how antibodies with long “loops” form may be important for HIV vaccine development. Read More

New information may help speed development of a vaccine or treatment for dengue fever. Read More

A new viral protein structure could jump-start vaccine development for two leading causes of lower respiratory disease in children and elderly adults. Read More

New details about the life cycle of respiratory syncytial virus (RSV) could aid the development of therapies to combat this leading cause of serious illness in infants and the elderly. Read More

Statins, traditionally known as cholesterol-lowering drugs, may reduce mortality among patients hospitalized with influenza, according to a new study released online by The Journal of Infectious Diseases. Read More

This Week on VUCast: A shark attack victim inspires a bionic breakthrough; why political prices are going up; and making a cappella cool. [vucastblurb]    … Read More

Antibodies to the 2009 H1N1 influenza strain reveal new insights into how antibody diversity forms and functions, with possible implications for designing flu vaccines. Read More

A report released by the Institute of Medicine confirms the safety of eight vaccines studied by a committee of experts. Evidence showed no links between immunization and serious conditions that have raised concerns, including Type 1 diabetes and autism. Read More

Vanderbilt researchers are seeking healthy adults ages 18-49 for a study testing a new vaccine against H5N1 influenza, a strain which has the potential to be the next pandemic flu virus. Read More